Adherence to nebulised antibiotics in cystic fibrosis-Reference-Cited by-同舟云学术

Adherence to nebulised antibiotics in cystic fibrosis

Published:2009-04 Issue:1 Volume:75 Page:141-144
ISSN:0738-3991
Container-title:Patient Education and Counseling
language:en
Short-container-title:Patient Education and Counseling

Author:

Latchford Gary,Duff Alistair,Quinn Joanne,Conway Steve,Conner Mark

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. Treatment adherence: terminology, incidence and conceptualisation;Meichenbaum,1987

2. Compliance with treatment in adult patients with cystic fibrosis;Conway;Thorax,1996

3. World Health Organisation adherence for long-term therapies: evidence for action. Switzerland: WHO; 2003. http://www.emro.who.int/ncd/Publications/adherence_report.pdf [retrieved 16.01.2008].

4. Determinants of adherence in adults with cystic fibrosis;Kettler;Thorax,2002

5. Methodological and conceptual issues in adherence;Myers,1998

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of amikacin lung delivery between AKITA® and eFlow rapid® nebulizers in healthy controls and patients with CF: A randomized cross-over trial;Respiratory Medicine and Research;2023-11

2. Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany;Pulmonary Pharmacology & Therapeutics;2023-06

3. Pulmonary;Practical Pharmaceutics;2023

4. Dry powder inhalation, part 2: the present and future;Expert Opinion on Drug Delivery;2022-08-19

5. Use of inhaled antibiotics among Danish patients with cystic fibrosis;Pediatric Pulmonology;2022-05-14